XML 57 R23.htm IDEA: XBRL DOCUMENT v2.4.0.8
GOODWILL AND OTHER INTANGIBLE ASSETS (Tables)
 6 Months Ended
Jun. 30, 2014
Goodwill and Intangible Assets Disclosure [Abstract]  
Schedule Of Changes In Carrying Amount Of Goodwill
Changes in the carrying amount of goodwill for the six months ended June 30, 2014 were as follows:
 
 
U.S.
Neurosurgery
 
U.S.
Instruments
 
U.S.
Extremities
 
U.S.
Spine
and
Other
 
International
 
Total
 
(In thousands)
Goodwill, gross
$
95,165

 
$
58,033

 
$
61,079

 
$
56,325

 
$
25,900

 
$
296,502

Accumulated impairment losses
—

 
—

 
—

 
(46,738
)
 
—

 
(46,738
)
Goodwill at December 31, 2013
95,165

 
58,033

 
61,079

 
9,587

 
25,900

 
249,764

Confluent Surgical acquisition
95,373

 
—

 
—

 
—

 
9,958

 
105,331

Foreign currency translation
(63
)
 
(19
)
 
(20
)
 
(3
)
 
(13
)
 
(118
)
Goodwill at June 30, 2014
$
190,475

 
$
58,014

 
$
61,059

 
$
9,584

 
$
35,845

 
$
354,977
Components Of Company's Identifiable Intangible Assets
The components of the Company’s identifiable intangible assets were as follows:
 
 
June 30, 2014
 
Weighted
Average
Life
 
Cost
 
Accumulated
Amortization
 
Net
 
(Dollars in thousands)
Completed technology
18 years
 
$
320,833

 
$
(54,339
)
 
$
266,494

Customer relationships
12 years
 
146,988

 
(84,400
)
 
62,588

Trademarks/brand names
31 years
 
33,686

 
(15,973
)
 
17,713

Trademarks/brand names
Indefinite
 
48,484

 
—

 
48,484

Supplier relationships
27 years
 
34,721

 
(10,049
)
 
24,672

All other (1)
4 years
 
4,620

 
(2,562
)
 
2,058

 
 
 
$
589,332

 
$
(167,323
)
 
$
422,009


 
December 31, 2013
 
Weighted
Average
Life
 
Cost
 
Accumulated
Amortization
 
Net
 
(Dollars in thousands)
Completed technology
12 years
 
$
81,238

 
$
(45,343
)
 
$
35,895

Customer relationships
12 years
 
146,627

 
(79,624
)
 
67,003

Trademarks/brand names
31 years
 
33,703

 
(15,648
)
 
18,055

Trademarks/brand names
Indefinite
 
48,484

 
—

 
48,484

Supplier relationships
27 years
 
34,721

 
(9,305
)
 
25,416

All other (1)
5 years
 
4,251

 
(1,941
)
 
2,310

 
 
 
$
349,024

 
$
(151,861
)
 
$
197,163


 
(1) 
At June 30, 2014 and December 31, 2013, all other included in-process research and development ("IPR&D") of $1.4 million in both periods, which was indefinite-lived.